The prevalence of CYP24A1 mutations in the general population is unknown, but may contribute to hypercalcemia, a condition with an estimated prevalence of 1/500 patients in the outpatient setting [126]. The gene discussed is CYP24A1; the disease is hypercalcemia disease.